Senate Introduces Long-Term Care Pharmacy Definition Act of 2021
The Senior Care Pharmacy Coalition Applauds This Crucial Step for Long-Term Care Pharmacies; Enabling Better Care for Vulnerable Populations
Washington, DC (May 12, 2021) – The bipartisan Long-Term Care Pharmacy Definition Act of 2021 was introduced today by Senator Tim Scott (R-SC) and Senator Mark Warner (D-VA), providing a solution to a convoluted, patchwork system governing long-term care (LTC) pharmacies. The Senior Care Pharmacy Coalition (SCPC) commends this step that allows LTC pharmacies to do what they do best: provide enhanced pharmacy and clinical services to 850,000 LTC residents every day.
“The Senior Care Pharmacy Coalition thanks Senators Tim Scott and Mark Warner for today’s introduction of the bipartisan Long-Term Care Pharmacy Definition Act of 2021, which lays the groundwork to finally establish a clear federal statutory definition for long-term care (LTC) pharmacies,” said Alan Rosenbloom, SCPC President and CEO. “This is a crucial development that will modernize governmental oversight of the sector and ensure regulatory consistency for all federal agencies.”
This bill defines LTC pharmacies as especially qualified to provide enhanced pharmacy and clinical services to patients with medically complex chronic conditions who rely extensively on prescription drugs to improve their health and quality of life. LTC pharmacies play an irreplaceable role in communities across the country, but for far too long they have been forced to navigate a vague and inconsistent regulatory framework that has made it increasingly difficult to meet patient needs in the community.
“This commonsense legislation would ensure clarity and consistency for our long-term care pharmacies without adding costs to our healthcare system,” said Senator Scott. “I urge my colleagues to support this bipartisan bill, which will make it easier for this important sector to navigate regulatory confusion and allow them to care and provide for our nation’s seniors.”
“The COVID-19 pandemic drastically changed the way many of our seniors receive their care, putting a greater emphasis on the need for specialized care provided by long-term care pharmacies. Unfortunately, under existing rules, these pharmacies are regulated in the same way as more traditional retail pharmacies, which has created unnecessary bureaucracy around providing life-saving medication during this unprecedented health crisis,” said Senator Warner. “My bipartisan bill with Senator Tim Scott (R-SC) creates a distinct definition for long-term care pharmacies to better reflect the specialized care they provide for the senior population they serve.”
“This absence of a clear definition became devastatingly apparent during the COVID-19 pandemic as LTC pharmacies witnessed an average revenue loss of 11%, while simultaneously experiencing 10% higher operating costs to continue providing high-quality health care for this vulnerable population,” said Alan Rosenbloom. “Without a definition, LTC pharmacies missed out on critical federal assistance from the Provider Relief Fund. SCPC wholeheartedly supports this legislation, and we encourage the House of Representatives to move forward with a companion bill in the immediate future.”
Senators James Lankford (R-OK), Tina Smith (D-MN), Susan Collins (R-ME), Debbie Stabenow (D-MI), Bill Cassidy (R-LA), and Jacky Rosen (D-NV) joined the bill as original co-sponsors.
# # #
About Senior Care Pharmacy Coalition
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies, representing 75% of the sector overall. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Rosenbloom: Curb PBMs’ power
Despite the purported value of pharmacy benefit managers (PBMs), drug prices remain unaffordable for many Americans (“Prescription drug pricing reform must rein in pharmacy benefit managers,” Web, Oct. 18). As middlemen between the manufacturers, pharmacies and consumers, PBMs are notorious for abusive business practices that impact both patients’ wallets and their access to prescription drugs, while gouging unaffiliated pharmacies.
Prescription Drug Middleman Potentially Profiting off Veterans
One of the three dominant U.S. pharmacy benefit managers (PBMs)—the middlemen that handle the vast majority of prescription drug plans in the United States—has instituted a scheme that has left roughly 400,000 active-duty and retired military households scrambling for a new pharmacy provider within the next week. Critics say the maneuver is a naked attempt by Express Scripts, the Cigna-owned PBM, to steer beneficiaries toward its own market-leading mail-order pharmacy.
The surprising group that will be hit hard by drug pricing reform
By Rachel CohrsSTAT Obviously, pharmaceutical companies are upset that they’re going to lose money from Medicare under Democrats’ new drug pricing law. But there’s another, less obvious group that’s concerned as well — long-term care pharmacies that serve almost entirely Medicare patients, and dispense the drugs that will likely enter the price negotiation program first. […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.